Bank Julius Baer & Co. Ltd, Zurich Fulgent Genetics, Inc. Transaction History

Bank Julius Baer & Co. Ltd, Zurich

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 09, 2022	SELL	$49.85 - $96.11 $4,087 - $7,881	-82 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$74.87 - $110.87 $2,096 - $3,104	28 Added 51.85%	82 $7,000
Q2 2021 Jul 23, 2021	SELL	$66.8 - $100.45 $19,372 - $29,130	-290 Reduced 84.3%	54 $5,000
Q1 2021 May 10, 2021	BUY	$59.3 - $183.85 $16,959 - $52,581	286 Added 493.1%	344 $33,000
Q4 2020 Feb 24, 2021	BUY	$31.01 - $52.1 $248 - $416	8 Added 16.0%	58 $3,000
Q4 2020 Feb 12, 2021	BUY	$31.01 - $52.1 $1,550 - $2,605	50 New	50 $3,000

200

16M

2.04M

14K

Ticker FLGT
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 30,265,800
Market Cap $521M
Description
Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...

Get notified when there are updates to the investment portfolio of Bank Julius Baer & Co. Ltd, Zurich, based on Form 13F filings with the SEC.

Stay updated on Bank Julius Baer & Co. Ltd, Zurich with notifications on news.